Li Kang Financials
| 6242 Stock | TWD 43.05 0.80 1.82% |
6242 |
Understanding current and past Li Kang Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Li Kang's financial statements are interrelated, with each one affecting the others. For example, an increase in Li Kang's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Li Kang's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Li Kang Biomedical. Check Li Kang's Beneish M Score to see the likelihood of Li Kang's management manipulating its earnings.
Li Kang Stock Summary
Li Kang competes with Taiwan Mobile, TWOWAY Communications, Tainet Communication, Union Insurance, and Central Reinsurance. Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drinks. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan. LI KANG operates under Travel Services classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 123 people.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0006242001 |
| Business Address | No 29, Huangong |
| Sector | Personal Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.likangbio.com |
| Phone | 886 6 233 7068 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Li Kang without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of 6242 Stock, because this is throwing your money away. Analyzing the key information contained in Li Kang's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Li Kang Key Financial Ratios
There are many critical financial ratios that Li Kang's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Li Kang Biomedical reports annually and quarterly.6242 Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Li Kang's current stock value. Our valuation model uses many indicators to compare Li Kang value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Li Kang competition to find correlations between indicators driving Li Kang's intrinsic value. More Info.Li Kang Biomedical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.62 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Li Kang Biomedical is roughly 1.60 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Li Kang's earnings, one of the primary drivers of an investment's value.Li Kang Biomedical Systematic Risk
Li Kang's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Li Kang volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Li Kang Biomedical correlated with the market. If Beta is less than 0 Li Kang generally moves in the opposite direction as compared to the market. If Li Kang Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Li Kang Biomedical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Li Kang is generally in the same direction as the market. If Beta > 1 Li Kang moves generally in the same direction as, but more than the movement of the benchmark.
Li Kang Thematic Clasifications
Li Kang Biomedical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Li Kang December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Li Kang help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Li Kang Biomedical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Li Kang Biomedical based on widely used predictive technical indicators. In general, we focus on analyzing 6242 Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Li Kang's daily price indicators and compare them against related drivers.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 4.37 | |||
| Value At Risk | (1.69) | |||
| Potential Upside | 1.37 |
Additional Tools for 6242 Stock Analysis
When running Li Kang's price analysis, check to measure Li Kang's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Li Kang is operating at the current time. Most of Li Kang's value examination focuses on studying past and present price action to predict the probability of Li Kang's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Li Kang's price. Additionally, you may evaluate how the addition of Li Kang to your portfolios can decrease your overall portfolio volatility.